$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Cabergoline standard dosage and daily medication guide
2026-02-01 22:25:32
Check Details
The efficacy, role and clinical application results of momelotinib
2026-02-01 22:25:32
Check Details
Types of adverse reactions of Biken Pronol Tablets (Bituvi) and how to deal with them when they occur
2026-02-01 22:25:32
Check Details
Is it reasonable to limit the treatment course of decavatinib to no more than two months?
2026-02-01 22:25:32
Check Details
Will taking Apremilast (Otelor) for 5 days and stopping for 3 days affect the efficacy and precautions?
2026-02-01 22:25:32
Check Details
How to safely adjust the dose of Valganciclovir in post-organ transplant infections
2026-02-01 22:25:32
Check Details
Analysis of the efficacy and applicable population of combined use of methylcobalamin and vitamin B1
2026-02-01 22:25:32
Check Details
Classification and treatment advantages of cobimetinib (cobimetinib) targeted drug and clinical research progress
2026-02-01 22:25:32
Check Details
Comparison of the differences between domestic and imported versions of macitentan and analysis of differences in efficacy
2026-02-01 22:25:32
Check Details
What are the common side effects of Tilorisen? Analysis of usage safety and precautions
2026-02-01 22:25:32
Check Details
A comprehensive guide to the common side effects and long-term safety of Pretomanid
2026-02-01 22:25:32
Check Details
Are there any risks with voclosporin soft capsule trial?
2026-02-01 22:25:32
Check Details
1
2
...
2255
2256
2257
2258
2259
2260
2261
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma